With its stock down 7.6% over the past three months, it is easy to disregard Pfizer (NYSE:PFE). We, however decided ...

Pfizer (PFE) closed the last trading session at $22.79, gaining 1.3% over the past four weeks, but there could be plenty of ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Sangamo Therapeutics, Inc.’s SGMO share price has surged by 5.70%, which has investors questioning if this is right time to ...

An unhealthy combination of factors resulted in an unhealthy day on the stock market for next-generation healthcare company ...

ORIC Pharmaceuticals, Inc.’s ORIC share price has dipped by 7.54%, which has investors questioning if this is right time to buy.

It's also a great place to start if you're looking for dividend stocks, as nearly every stock on the Dow Jones Industrial ...

On Wednesday, Goldman Sachs adjusted its outlook on shares of Pfizer Inc (NYSE:PFE) shares, raising the price target to $34 from ...

Main Capital, a boutique investment firm, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here.